Article Versions Notes

Barrachina MN, Izquierdo I, Hermida-Nogueira L, Morán LA, Pérez A, Arroyo AB, García-Barberá N, González-Conejero R, Troitiño S, Eble JA, et al. The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential. International Journal of Molecular Sciences. 2021; 22(7):3304. https://doi.org/10.3390/ijms22073304

Barrachina, María N., Irene Izquierdo, Lidia Hermida-Nogueira, Luis A. Morán, Amparo Pérez, Ana B. Arroyo, Nuria García-Barberá, Rocío González-Conejero, Sara Troitiño, Johannes A. Eble, and et al. 2021. "The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential" International Journal of Molecular Sciences 22, no. 7: 3304. https://doi.org/10.3390/ijms22073304

Barrachina, M. N., Izquierdo, I., Hermida-Nogueira, L., Morán, L. A., Pérez, A., Arroyo, A. B., García-Barberá, N., González-Conejero, R., Troitiño, S., Eble, J. A., Rivera, J., Martínez, C., Loza, M. I., Domínguez, E., & García, Á. (2021). The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential. International Journal of Molecular Sciences, 22(7), 3304. https://doi.org/10.3390/ijms22073304